A new research published in Neuropathology and Applied Neurobiology, has established that Toxic proteins within the brain that cause Parkinson’s disease and Lewy body dementia have the potential to help develop new targeted therapies.
Research into modified RNA messages could help treat diseases and develop new therapies
University of Nottingham experts – led by Dr Helen Miranda Knight – have discovered that the modification of ribonucleic acid (RNA) in human brain tissue is disrupted among neurodegenerative diseases. These conditions include Lewy bodies dementia and Parkinson’s disease.
You can read the full article here:
https://onlinelibrary.wiley.com/action/doSearch?AllField=modified+m6a&SeriesKey=13652990
Related Posts
31 July 2024
Meet our AI- driven robot
We are more than proud to announce that, through a tight collaboration with SUPSI (Università della Svizzera Italiana) and our partner KeepOne Swiss Vision Technology, we have developed the…
9 January 2024
Please join us in congratulating Fabio for his first successful year in Elixi!
Let's put a face to a name! Let us introduce you to one of the "pillars" of our organisation, our Head of Quality and Medical department, the mighty Fabio Macchi! Fabio joined us exactly…
13 September 2023
Come and meet us at Expopharm 2023! 27 -30 September in DÜSSELDORF.
Come and meet us at Expopharm 2023! 27 -30 September in DÜSSELDORF. Our colleagues Luca Schincaglia and Marco Ferrario will be there and happy to chat with you! #expopharm2023 #expopharm…